Katz A - Search Results

1

Pretreatment CA 19-9 level as a prognostic factor in patients with advanced pancreatic cancer treated with gemcitabine.

Saad ED, Machado MC, Wajsbrot D, Abramoff R, Hoff PM, Tabacof J, Katz A, Simon SD, Gansl RC. Saad ED, et al. Among authors: katz a. Int J Gastrointest Cancer. 2002;32(1):35-41. doi: 10.1385/IJGC:32:1:35. Int J Gastrointest Cancer. 2002. PMID: 12630768

2

Quality-of-life benefits and evidence of antitumour activity for patients with brain metastases treated with gefitinib.

Katz A, Zalewski P. Katz A, et al. Br J Cancer. 2003 Dec;89 Suppl 2(Suppl 2):S15-8. doi: 10.1038/sj.bjc.6601478. Br J Cancer. 2003. PMID: 14661048 Free PMC article. Review.

3

Primary systemic chemotherapy of invasive lobular carcinoma of the breast.

Katz A, Saad ED, Porter P, Pusztai L. Katz A, et al. Lancet Oncol. 2007 Jan;8(1):55-62. doi: 10.1016/S1470-2045(06)71011-7. Lancet Oncol. 2007. PMID: 17196511 Review.

4

Progression-free survival and time to progression as primary end points in advanced breast cancer: often used, sometimes loosely defined.

Saad ED, Katz A. Saad ED, et al. Among authors: katz a. Ann Oncol. 2009 Mar;20(3):460-4. doi: 10.1093/annonc/mdn670. Epub 2008 Dec 18. Ann Oncol. 2009. PMID: 19095776 Free article.

5

CALGB 9633: an underpowered trial with a methodologically questionable conclusion.

Katz A, Saad ED. Katz A, et al. J Clin Oncol. 2009 May 1;27(13):2300-1; author reply 2301-2. doi: 10.1200/JCO.2008.21.1565. Epub 2009 Mar 30. J Clin Oncol. 2009. PMID: 19332712 No abstract available.

6

Endocrine therapy plus zoledronic acid in premenopausal breast cancer.

Katz A, Calabrich A, Saad ED. Katz A, et al. N Engl J Med. 2009 May 28;360(22):2367-8; author reply 2369-70. N Engl J Med. 2009. PMID: 19484814 No abstract available.

7

Progression-free survival as surrogate and as true end point: insights from the breast and colorectal cancer literature.

Saad ED, Katz A, Hoff PM, Buyse M. Saad ED, et al. Among authors: katz a. Ann Oncol. 2010 Jan;21(1):7-12. doi: 10.1093/annonc/mdp523. Epub 2009 Nov 9. Ann Oncol. 2010. PMID: 19901012 Free article. Review.

8

Overall survival and post-progression survival in advanced breast cancer: a review of recent randomized clinical trials.

Saad ED, Katz A, Buyse M. Saad ED, et al. Among authors: katz a. J Clin Oncol. 2010 Apr 10;28(11):1958-62. doi: 10.1200/JCO.2009.25.5414. Epub 2010 Mar 1. J Clin Oncol. 2010. PMID: 20194852 Review.

9

[Overall survival and other clinical outcomes in breast cancer :current situation and controversies].

Machado KK, Katz A, Buyse M, Saad ED. Machado KK, et al. Among authors: katz a. Rev Assoc Med Bras (1992). 2010 Sep-Oct;56(5):514-6. doi: 10.1590/s0104-42302010000500008. Rev Assoc Med Bras (1992). 2010. PMID: 21152819 Free article. Review. Portuguese. No abstract available.

10

Assessment of quality of life in advanced breast cancer. An overview of randomized phase III trials.

Adamowicz K, Jassem J, Katz A, Saad ED. Adamowicz K, et al. Among authors: katz a. Cancer Treat Rev. 2012 Aug;38(5):554-8. doi: 10.1016/j.ctrv.2011.07.002. Epub 2011 Jul 31. Cancer Treat Rev. 2012. PMID: 21807465

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3,316 results

Search Page

Filters